These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32682372)

  • 1. Therapeutic and Mechanistic Approaches of
    Al-Bari MAA; Hossain S; Mia U; Al Mamun MA
    Curr Drug Targets; 2020; 21(16):1687-1702. PubMed ID: 32682372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tridax procumbens flavonoids promote osteoblast differentiation and bone formation.
    Al Mamun MA; Hosen MJ; Islam K; Khatun A; Alam MM; Al-Bari MA
    Biol Res; 2015 Nov; 48():65. PubMed ID: 26581452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavonoids compounds from Tridax procumbens inhibit osteoclast differentiation by down-regulating c-Fos activation.
    Al Mamun MA; Asim MMH; Sahin MAZ; Al-Bari MAA
    J Cell Mol Med; 2020 Feb; 24(4):2542-2551. PubMed ID: 31919976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tridax procumbens flavonoids: a prospective bioactive compound increased osteoblast differentiation and trabecular bone formation.
    Al Mamun MA; Hosen MJ; Khatun A; Alam MM; Al-Bari MAA
    Biol Res; 2017 Sep; 50(1):28. PubMed ID: 28886722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonoids isolated from Tridax procumbens (TPF) inhibit osteoclasts differentiation and bone resorption.
    Al Mamun MA; Islam K; Alam MJ; Khatun A; Alam MM; Al-Bari MA; Alam MJ
    Biol Res; 2015 Sep; 48(1):51. PubMed ID: 26363910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu maxim.
    Xue L; Jiang Y; Han T; Zhang N; Qin L; Xin H; Zhang Q
    J Ethnopharmacol; 2016 Nov; 192():370-381. PubMed ID: 27422162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New pathophysological relevant metabolic pathways in osteoporosis. Future innovative therapies?].
    Neumann E
    Z Rheumatol; 2006 Sep; 65(5):400, 402-6. PubMed ID: 16924451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current advances in regulation of bone homeostasis.
    Al-Bari AA; Al Mamun A
    FASEB Bioadv; 2020 Nov; 2(11):668-679. PubMed ID: 33205007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
    Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
    J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblast-n-Osteoclast: Making Headway to Osteoporosis Treatment.
    Kaur M; Nagpal M; Singh M
    Curr Drug Targets; 2020; 21(16):1640-1651. PubMed ID: 32735518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolactin A protects against LPS-induced bone loss by regulation of bone remodeling.
    Sapkota M; Gao M; Li L; Yang M; Shrestha SK; Choi H; Soh Y
    Eur J Pharmacol; 2020 Sep; 883():173305. PubMed ID: 32673673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of icariin on bone metabolism and its potential clinical application.
    Wang Z; Wang D; Yang D; Zhen W; Zhang J; Peng S
    Osteoporos Int; 2018 Mar; 29(3):535-544. PubMed ID: 29110063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The osteoclast, bone remodelling and treatment of metabolic bone disease.
    Boyce BF; Rosenberg E; de Papp AE; Duong LT
    Eur J Clin Invest; 2012 Dec; 42(12):1332-41. PubMed ID: 22998735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavonoid intake and bone health.
    Weaver CM; Alekel DL; Ward WE; Ronis MJ
    J Nutr Gerontol Geriatr; 2012; 31(3):239-53. PubMed ID: 22888840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Treatments for Osteoporosis-Which Combination of Pills Is the Best among the Bad?
    Tonk CH; Shoushrah SH; Babczyk P; El Khaldi-Hansen B; Schulze M; Herten M; Tobiasch E
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological agents and natural compounds: available treatments for osteoporosis.
    Martiniakova M; Babikova M; Omelka R
    J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory Tweak/Fn14 signaling pathway as a potent target for controlling bone loss.
    Du YY; Zhao YX; Liu YP; Liu W; Wang MM; Yuan CM
    Biomed Pharmacother; 2015 Mar; 70():170-3. PubMed ID: 25776497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory, cyclooxygenase inhibitory and antioxidant activities of standardized extracts of Tridax procumbens L.
    Jachak SM; Gautam R; Selvam C; Madhan H; Srivastava A; Khan T
    Fitoterapia; 2011 Mar; 82(2):173-7. PubMed ID: 20804828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation.
    Cheon YH; Lee CH; Kim S; Park GD; Kwak SC; Cho HJ; Kim JY; Lee MS
    Biomed Pharmacother; 2021 Jul; 139():111697. PubMed ID: 34243614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-osteoporotic activity of harpagide by regulation of bone formation in osteoblast cell culture and ovariectomy-induced bone loss mouse models.
    Chung HJ; Kyung Kim W; Joo Park H; Cho L; Kim MR; Kim MJ; Shin JS; Ho Lee J; Ha IH; Kook Lee S
    J Ethnopharmacol; 2016 Feb; 179():66-75. PubMed ID: 26712566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.